Healthcare Providers Archives

Top 3 Things You Don’t Want to Miss from Glooko at ADCES23

If you’re planning to attend the Association of Diabetes Care & Education Specialists’ ADCES23 in Houston, Team Glooko wants to meet you at booth #1101 to share the latest updates to our digital health technologies.

Some of the exciting activities that you can expect from us at the meeting:

1. Product Demos: We’ll provide live demos of the recently redesigned Glooko® Mobile App, available now in the App Store and Google Play Store. The sleek, new design improves onboarding for patients with diabetes and makes it even easier for them to input, view and understand their health data.
2. Ask An Expert: Our booth will host experienced clinicians who will share how their clinics and patients are benefitting from Glooko’s connected care platforms and achieving better health outcomes. Experts at these informal sessions include:
  - Gary Scheiner, MS, CDCES, Integrated Diabetes Services (Friday: 9 to 10 a.m.; Saturday: 11:30 a.m. to 12:30 p.m.) He will cover data analysis and interpretation for a variety of devices, including CGMs, insulin pumps and AID systems. Gary will walk through the various Glooko reports he relies on for different patients and the insights they provide.
  - Susan Weiner, RDN, CDCES, Susan Weiner Nutrition (Friday: 11:30 a.m. to 12:30 p.m.; Saturday: 9 to 10 a.m.) She will review how best to support patients in their self-care by leveraging and incorporating Glooko into their daily lives. She’ll also review various functionalities within the Glooko Mobile App and what she likes most about them from a patient engagement and user experience standpoint.
  - Allison Nimlos, LMFT, CDCES, Greater Than Counseling & Coaching (Saturday: 2:30 to 3:30 p.m.) She will focus on the psychosocial aspects of diabetes care management, including how data can be both empowering and anxiety inducing. Allison will discuss how she onboards newly diagnosed patients by leveraging the app’s different data visualization tools to best support the patient’s mental well-being and desired behavioral changes.
  - Bridget Wood, RD, LD, CDCES, Glooko (Friday: 10 to 11:30 a.m.; Sunday: 9 to 11 a.m.) She will discuss how she uses Glooko as a person living with Type I diabetes. Bridget will also share how to enhance a virtual diabetes coaching practice using the health data in the Glooko Mobile App from both the provider and patient experiences.
3. Food Tracker: People with diabetes can use the innovative food tracker feature of the Glooko® Mobile App to easily log their food intake, view their food data alongside data from compatible diabetes and health monitoring devices, medications and insulin, and keep a historical account of how food affects their chronic condition.

Be sure to also check out our blog series from Glooko’s very own experts.

With maintaining a healthy meal plan to keep blood glucose levels in target range being important, take some time to explore healthy eating and living tips designed for people with diabetes from Bridget Wood, RD, LD, CDCES.
Curious about the many benefits of physical activity for people with diabetes and how to get started with an exercise program? Explore ‘Move More’ from Sanaz Nosrat, PhD, CSCS, ACE PT.

See you in Houston!

MKT-0479 01

Glooko Showcases its Connected Care Solutions that Improve Health Outcomes at the American Diabetes Association (ADA) 83rd Scientific Sessions

At the American Diabetes Association (ADA) 83rd Scientific Sessions in San Diego, Team Glooko was thrilled to connect with so many old and new friends on the tradeshow floor and during industry events.

During the conference, our team showcased how our innovative connected care platforms for people living with diabetes and their healthcare providers improve health outcomes. We also provided live demos of the Glooko® Mobile App, which has a sleek new design that makes diabetes management even easier. The redesign boasts improved patient onboarding and streamlined data visualizations that allow for easy inputting, viewing and understanding of health data.

At our booth, we hosted “Ask an Expert” where leading clinicians, including University of Missouri-Kansas City School of Medicine’s Mark Clements, MD PhD CPI FAAP, Cleveland Clinic’s Dr. M. Cecilia Lansang, Rady Children’s Hospital’s Dr. Carla Demeterco-Berggren and Integrated Diabetes Services’ Gary Scheiner, shared how their clinics and patients benefit from the Glooko connected care platforms. The expert clinicians also discussed Glooko’s EHR integration, patient engagement, remote care and population health capabilities with attendees.

Representatives from Dexcom, one of our many device partners, visited our booth to share how their continuous glucose monitors (CGMs) work with our platform for improved diabetes management.

On the tradeshow floor, our team talked with some users of our connected care platforms to hear how Glooko has positively impacted their clinics. Here’s what they said:

We were also a proud sponsor of the sold-out Summer 2023 DiabetesMine D-Data ExChange, where we held live demos of Glooko. The event was packed with informative and inspiring discussions on the latest developments in diabetes technology.

We look forward to showcasing our latest digital health innovations next year at ADA 2024 in Orlando!

MKT-0473 01

Glooko Showcases Its Connected Care Innovations and Strong Partnerships at ATTD 2023

At the 16th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2023) in Berlin, Team Glooko had the exciting opportunity to meet new and old friends on the tradeshow floor and offer live demonstrations of the innovative Glooko and Glooko XT connected care platforms at our stand.

And the conference was all about our partnerships with leading global diabetes companies.

We hosted Dexcom, Novo Nordisk and Tandem in our stand to demonstrate how the Glooko platform works with their products for people living with diabetes and their care teams. We also joined these three industry partners in their stands to demonstrate how the Glooko connected care platform works with their digital health innovations and devices.

We announced our new partnership with Sanofi, which gives people with diabetes more choices in customizing their diabetes management by integrating the SoloSmart® cap for SoloStar® insulin pens with the Glooko connected care platform. This new integration will help improve insulin management and tracking, while supporting insulin dosing data.

While we already support an extensive and growing list of diabetes and health monitoring devices, Team Glooko met with over 45 of our partners to discuss how to bring more digital health solutions to healthcare providers.

Our poster presentation, “Remote Patient Monitoring and Glycemic Control Trends During the COVID-19 Pandemic,” highlighted the effectiveness of our remote care platform’s capabilities when healthcare delivery needed to rapidly shift due to stay-at-home orders, but clinicians needed to remain engaged and provide care to their patients with diabetes.

We were also a proud sponsor of the diaTribe Foundation and ATTD’s panel discussion, “Solvable Problems in Diabetes,” with leading experts around continuous glucose monitoring, time in range and associated therapeutic and data-driven interventions for people living with diabetes.

After an action-packed few days, our team is already looking forward to showcasing our latest innovations next year at ATTD 2024 in Florence.

MKT-0429 01

Glooko Demonstrates Better Diabetes Management and Outcomes Through Clinical Studies

At Glooko, we improve the health outcomes of people with diabetes and related chronic conditions through our personalized, intelligent, connected care platform. Our proven technologies make lives better by revolutionizing the connection between patients and healthcare providers, driving patient engagement and adherence via digital therapeutics, and accelerating the speed of clinical trials.

Through multiple clinical studies conducted, we’ve observed immediate and sustained improvements across multiple glycemic outcomes following remote patient monitoring (RPM). These findings show that RPM provides multiple clinical benefits and improved outcomes for people with diabetes.

Some of the highlights of our real-world data studies include:

Delivering Improved and Sustained Glycemic Control^1,2,3
Use of the Glooko Mobile App Improving Glycemic Outcomes in 2 Months⁴
Declining Patient Outcomes 6-8 Weeks After Stopping Using Glooko⁵

Download the infographic (PDF) below for findings from our studies.

1. Sheng T et al. Glycemic Improvements Following Mobile-Enabled Remote Patient Monitoring: A Randomized Control Study, ADA Scientific Sessions, June 2020. 2. Clements M, Duffee J and McCarther D. Remote patient monitoring for adults with type 2 diabetes. ADCES Research Sessions, August, 2020. 3. Sheng T, Parks L and Clements M. Remote patient monitoring in the real world: Immediate and long-term improvements in glycemic control. American Association of Diabetes Educators (AADE) Annual Meeting, Houston TX. August, 2019. 4. Offringa R et al. Digital diabetes management application improves glycemic outcomes in people with type 1 and type 2 diabetes. Journal of diabetes science and technology, 12(3), 701-708. 2018. 5. Sheng T et al. Mobile-Enabled Food Logging is Associated with Improved Glycemic Management in the Real World. Diabetes Technology Meeting (DTM), 2019. 6. Abad R et al. Use of mobile-enabled reminders feature is associated with improved behavioral and glycemic outcomes in the real world. American Diabetes Association (ADA), Scientific Sessions, 2019. 7. Babikian S et al. Deteriorating Glucose Control in Patients with Diabetes after Disengagement from a Mobile Health App. Diabetes Technology Meeting, Poster, 2020.

MKT-0084 01

Glooko Unveils Positive Remote Patient Monitoring Data at the 2022 IDF World Diabetes Congress

Glooko, a leading provider of intelligent, connected care solutions and remote patient monitoring (RPM) for people with diabetes and related chronic conditions, presented positive data from two recent studies on remote patient monitoring at the 2022 IDF World Diabetes Congress.

The first study presented by Team Glooko at the Congress, Cost and Outcomes of a Diabetes Remote Patient Monitoring System: A Simulation Analysis, was the company’s inaugural study using a health economics and outcomes research (HEOR) simulation model. In a randomized controlled trial of RPM and digital therapeutics (DTx), the intervention resulted in significantly improved HbA1c in patients with type 2 diabetes (T2D). Incorporating these results into a microsimulation model of longer-term complications, mortality and costs demonstrated the potential for RPM and DTx to elicit health gains and cost savings among people with diabetes.

The second study presented by Team Glooko, The Impact of Remote Patient Monitoring on Glycated Hemoglobin for Type 2 Diabetes: A Randomized Controlled Trial, demonstrated that a comprehensive 24-week RPM diabetes management program was more effective in improving HbA1c compared to usual care for adults with T2D.

These studies further showcase the clinical and economic benefits of the Glooko platform, which is sold to healthcare providers globally, and available for free as a mobile app to patients.

Team Glooko will continue to highlight the benefits of our connected care platform for diabetes and related chronic conditions at industry events in 2023.

MKT-0413 01

Glooko’s ADCES22 Sessions Highlight Food Tracking Features, Virtual Employee Wellness Coaching and Improving Diabetes Care Management

Recently, Glooko exhibited at ADCES22, the premier annual conference from the Association of Diabetes Care & Education Specialists covering all things diabetes care, education and technology.

Not only was it refreshing to meet our customers, colleagues and partners again in-person, a key focus of the event was on how to better help patients with diabetes during these changing times.

At the event, our very own registered dietitian and certified diabetes care and education specialist, Bridget Wood, shared during a Center Stage session how people living with diabetes can use the food tracker functionality within the Glooko mobile app to log their daily meals via search, voice capture and barcode scanner. The very handy food database has over 500,000 individual items, including unique regional food items from Germany, the U.K., Spain and France. Wood also highlighted how our mobile app has the capability to simultaneously add multiple lifestyle events, like medication, insulin, exercise and notes, which can be viewed alongside glucose data to reveal trends and patterns.

Along with Cecelia Health, Glooko presented a case study on how a virtual employee wellness program comprised of our digital health app for people with diabetes and virtual coaching can generate high levels of participation and improve patient outcomes.

During a Coffee Talk, Gene Arnold from Johns Hopkins Medicine and Gary Scheiner from Integrated Diabetes Services participated in a lively discussion with Glooko Chief Medical Officer Dr. Mark Clements. They discussed the clinical challenges faced when trying to educate people with diabetes without accurate data, which Glooko data visualizations to use and how clinicians are incorporating remote patient monitoring and population health management into their practices.

For those that missed it live, watch the conversation below.

MKT-0086

Academy™ for U.K. and Ireland Healthcare Providers Adds Module to Further Training on Connected Pens Used by People with Diabetes

This month, Academy™, a free educational platform Glooko developed in conjunction with the Association of British Clinical Diabetologists (ABCD)/Diabetes Technology Network UK (DTN-UK) and DigiBete, launched a new training module on connected pens used by people with diabetes. This marks the eighth module on the CPD accredited platform for healthcare professionals in the U.K and Ireland to improve their knowledge of diabetes technologies.

The new course educates healthcare professionals on the benefits of connected pens, the different types of smart insulin pens available and how the data generated by these pens can be used in clinical practice to support people with diabetes.

“Smart pens are another emerging tool that can help us get a more complete picture of what is causing the ups and downs that are so frustrating for people living with diabetes,” said Dr. Pratik Choudhary, professor of diabetes, Leicester Diabetes Centre, University of Leicester, UK and chair of DTN-UK. “We’re really pleased to launch the latest course in Academy™ to help support healthcare providers in making the best use of this technology.”

For people with diabetes, connected pens allow accurate and up-to-date recording of the timing and doses of insulin administration. Healthcare teams supporting patients using connected pens are able to gather a more complete picture of their patients’ diabetes therapy and can help understand causes of high or low blood glucose readings. This innovative connected pen technology combined with digital health platforms packed with data, like Glooko, can enable care teams to make informed decisions around insulin dosing for their patients.

“Connected pens are the latest exciting diabetes technology development, designed to enable integration of both glucose and insulin data to facilitate more detailed and informed discussions in the diabetes clinic,” said Dr. Emma Wilmot, consultant diabetologist, University Hospitals of Derby & Burton; founder, ABCD/DTN-UK; and honorary (clinical) associate professor, University of Nottingham.

Healthcare professionals in the U.K. and Ireland who are interested in advancing their knowledge of the latest diabetes technologies can register for Academy™ for free.

MKT-0349 01

Glooko Adds New Enhancements to Billing Export Feature to Streamline Submitting CPT Codes for Remote Patient Monitoring Reimbursement

Glooko recently introduced new enhancements to the billing export feature in Population Health Analytics for professional users with Glooko Enterprise accounts. The new features provide healthcare providers and care teams supporting patients with diabetes and related chronic conditions the information needed to properly bill CPT codes for remote patient monitoring (RPM) activities.

This evolution of Population Health Analytics, a tool available in our Glooko platform that creates advanced filters on patient populations, targets at-risk patients and tracks statistics post-intervention, now allows care teams to better serve their patients and helps them easily determine which patients are eligible for RPM reimbursement for a given calendar month.

These new enhancements provide dates of first in-clinic upload, any in-clinic uploads present during the selected date range and now clearly defined data for the completion of 16 days of remote data uploads required to meet billing requirements. Users will now see two columns added to their billing export CSV file for the information needed to bill for RPM within a calendar month.

“These enhancements provide healthcare providers and care teams using our digital health platform with the information needed to more efficiently and easily bill for RPM using the proper CPT codes,” said Glooko Chief Commercial Officer Zach Henderson. “We’re proud of Team Glooko’s efforts to create a more streamlined and quicker process for busy care teams seeking reimbursement using billing codes that support RPM efforts aimed at improving care for people with diabetes and related chronic conditions.”

In the recent 2022 Final Rule, Centers for Medicare and Medicaid Services (CMS) showed support for telehealth and RPM with five updated billing codes.

99543: Initial setup of the device, including patient education on use of equipment for RPM.
99454: Monthly remote monitoring with daily recordings. Billed each calendar month and must have a minimum of 16 days of remotely uploaded data.
99457: Monitoring and treatment management, which requires interactive communication between the patient and caregiver for the first 20 minutes during the calendar month.
99458: Each additional 20 minutes of interactive communication between the patient and caregiver during the calendar month.
99091: The time it takes for qualified clinical staff to gather, interpret and process monitoring data, at least 30 minutes every 30 days.

For more information on reimbursement payments and to learn how the Glooko digital health platform provides a better economic value to healthcare providers, contact Team Glooko or download a PDF on our new Population Health Billing Export Feature.

Per CMS policy on reimbursements, patients must agree and opt-in to be enrolled in an RPM program to qualify for the minimum of 16 days of data captured in a 30-day period. Not all payers reimburse for CPT RPM. Reimbursement policies vary by state and payer, please consult your billing specialist on policies for your local area or region.

MKT-0343 01

5 Key Takeaways about Remote Patient Monitoring from HIMSS22

HIMSS22 was filled with collaboration, especially about RPM. Here are five key takeaways from Team Glooko.

#1: The key to achieving RPM success is ease of use.

Ease of use is key when it comes to RPM success. There has been a proven sustained reduction in HbA1c with Glooko RPM for patients with type 2 diabetes, which shows how imperative it is to have an easy-to-use solution for both patients and care teams.

„Data should flow to the app with minimal patient effort and on the other side, every member of the care team should see it on a screen of their choice be it an electronic health record (EHR) or a population health management (PHM) app.“

glooko-prakash-menon — Prakash Menon
Chief Technology Officer at Glooko

#2: Innovative RPM solutions empower patients and care teams.

Managing chronic conditions effectively is critically important. Innovative RPM solutions empower patients, healthcare providers and health plans’ diabetes and chronic care management teams to manage conditions more effectively. Adopting digital health technology to manage patient populations‘ health data helps reduce the provider’s cognitive burden by securing all data available on a single platform for each visit, which allows effective care delivery models.

“The players in this connected care ecosystem all need to share the same data sets and work toward improved health outcomes in order to increase the quality of care and reimbursement by payers.”

glooko-derek-kren — Derek Kren
Vice President, Payer & Employer at Glooko

#3: RPM breaks down the silos amongst care teams.

Silos in healthcare are a thing of the past. Coordination and collaboration are key to effective treatment, and digital RPM solutions make records streamlined like never before.

“These innovative solutions get patient-centric information to the right place and result in less chart chasing and better cross-care team coordination for people with chronic conditions like diabetes.”

glooko-kevin-brubaker — Kevin Brubaker
Regional Vice President of Enterprise Health Systems at Glooko

#4: RPM creates connected care.

RPM creates seamless connected care between clinicians and people living with chronic conditions. In the context of connected care, mobile-enabled RPM involving connected diabetes devices and coaching can improve access to care and glycemic outcomes.

“This healthcare delivery method enables care teams to receive real-time data on their patients and allows them the opportunity to make adjustments to improve health outcomes. The efficiency that RPM creates can be seen immensely from both the clinician and person living with these conditions.”

glooko-cameron-trotter — Cameron Trotter
Product Marketing Manager at Glooko

#5: RPM is here to stay.

There’s a lot of interest in the RPM space as a result of COVID-19. Telehealth grew during COVID-19, and the use of these digital health platforms are here to stay. Glooko has, and continues to, discuss the future of telehealth in the ever-changing healthcare landscape.

“We’re seeing that RPM and the use of digital health platforms will continue well beyond the pandemic as it’s become an effective way for patients and their healthcare providers to collaborate on their care plans.”

glooko-laura-mensch — Laura Mensch
Senior Account Manager at Glooko

Final Thoughts

Team Glooko observed a vast amount about RPM during HIMSS22:

Ease of use is the key to RPM success.
Innovative RPM solutions empower not only patients, but also care teams.
RPM breaks down silos amongst care teams, allowing for cross-team patient care.
Blood glucose and insulin-related statistics
Seamless, connected care starts with RPM.
RPM and telehealth will be continued practice for the future.

Watch this video to learn more about Glooko at HIMSS22:

If you missed a live demo at HIMSS22, no worries! Contact us now, and a team member will reach out shortly to arrange a demo.

MKT-0345 01

Glooko Webinar with Fierce Healthcare Covers Promising Outlook for Telehealth and Remote Patient Monitoring

Telehealth and remote patient monitoring (RPM) have been found to effectively manage patient and population health.

During a webinar with Fierce Healthcare last month, Glooko CEO Russ Johannesson joined Tufia Haddad, MD, Chair of Practice Innovation and Platform, The Mayo Clinic and Professor Carri W. Chan, PhD, Professor, Division of Decision, Risk and Operations and Faculty Director, Healthcare and Pharmaceutical Management Program, Columbia Business School, to discuss the benefits of healthcare providers using these innovative healthcare technologies to treat patients.

The panel began with a deep dive into what each leader learned on the effective use of remote care during the COVID-19 pandemic.

“Through clinical research, we’ve seen how remote patient monitoring positively affects people with diabetes, who are more likely to experience improved health outcomes, and healthcare providers, who are able to improve their standard of care,” said Johannesson. “What we’ve learned about telehealth visits is patients appreciate the ease of access, the more frequent touchpoints with their care teams and the overall convenience, but they do want remote and in-person care working together seamlessly moving forward.”

Haddad and Chan had also seen the rapid adoption and phenomenal growth of telehealth and virtual care services as a result of COVID-19 and patients being more open due to receiving safe continuous care from home.

Throughout the webinar, the leaders also shared insights on a variety of topics related to RPM and telehealth, including what clinical research is telling us about which patients who are benefitting the most, cost effectiveness and ROI, promising applications and what barriers, including health disparities, that exist that would halt widespread adoption.

Watch the full webinar below for more insights and contact our team to learn how remote patient monitoring can help improve the health outcomes of people with diabetes and related chronic conditions.

MKT-0342 01

Glooko Blog

Kategorie: Healthcare Providers